Alkermes (ALKS) EBT Margin (2010 - 2026)
Alkermes (ALKS) recorded EBT Margin of -0.38% in Q2 2026, down 27.21 percentage points from 26.84% a year earlier but up 15.38 percentage points from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' EBT Margin came in at 5.84% as of Jun 30, 2026, down 21.43 percentage points year-over-year; for FY2025, it was 19.75%, down 8.74 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +29.04 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 28.49% in FY2024 (+3.15 pp), 25.34% in FY2023 (+28.14 pp), -2.80% in FY2022 (-10.27 pp) and 7.47% in FY2021 (+16.77 pp).
- Quarterly EBT Margin has ranged from -26.70% in Q3 2022 to 45.65% in Q2 2023 over the past five years.
- On a year-over-year basis, EBT Margin has declined for six consecutive quarters, with an average year-over-year change of -7.16 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 57.69 percentage points in Q2 2023, against a drop of 27.21 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -15.76% (Q1 2026), 15.70% (Q4 2025) and 25.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Alkermes | 6.84 Bn | 3.97 Bn | 397.90 Mn | -0.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.38% |
| Mar 31, 2026 | -15.76% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | 25.56% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 39.51% |
| Sep 30, 2024 | 29.15% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 13.39% |
| Dec 31, 2023 | 15.45% |
| Sep 30, 2023 | 24.34% |
| Jun 30, 2023 | 45.65% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | 37.58% |
| Sep 30, 2022 | -26.70% |
| Jun 30, 2022 | -12.04% |
| Mar 31, 2022 | -16.15% |
| Dec 31, 2021 | 39.22% |
| Sep 30, 2021 | -9.02% |
API Access
Alkermes EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();